Horizon Therapeutics Canada
Registration:
5
of
5
(2024-05-21
to
present)
Details Regarding the Identified Subject Matter
Subject matters
|
Details
|
Categories
|
Health
|
Food and Drugs Act, specifically with respect to the approval, regulation and life-cycle management of therapeutic products
|
Policies or Program
|
Health
|
Health Canada's Special Access Program (SAP) and associated regulations and guidelines
|
Regulation, Policies or Program
|
Health
|
Health Canada Regulatory Review of Drugs and Devices, including potential regulatory reforms with respect to drugs for rare diseases
|
Policies or Program
|
Health
|
Health system policies with respect to pharmaceuticals, including drugs for rare diseases
|
Policies or Program
|
Economic Development, Industry, Intellectual Property, Research and Development, Science and Technology
|
Innovation agenda led by Innovation, Science and Economic Development Canada, particularly with respect to the life sciences industry
|
Policies or Program
|
Health
|
Patented Medicine Prices Review Board (PMPRB) guidelines with respect to non-excessive pricing of patented medicines
|
Policies or Program
|
Health
|
Patented Medicine Prices Review Board (PMPRB) regulations with respect to non-excessive pricing of patented medicines
|
Regulation
|